Using PLK1 as a therapeutic target needs to be approached expertly to avoid undesirable outcomes due to the complex role of the level of CIN and the role of PLK1 in essential cell processes. This evidence concerns the gene PLK1 and cervical squamous intraepithelial neoplasia.